This is a study to evaluate the safety and effectiveness of a combination of a new med (ABT-335) and Crestor to each med alone in patients with dyslipidemia. The study will look at the meds' effects on patients' levels of good cholesterol, bad cholesterol, and triglycerides. This national study is currently recruiting patients.
Read moreThe JUPITER study has been the subject of countless headlines reporting the unprecedented reduction in heart attacks with the cholesterol... Read more »
According to U.S. researchers, acyclovir, a drug that suppresses herpes simplex virus-2, does not reduce HIV risk when taken by people infected by... Read more »
A new study suggests that the combination med Vytorin (sold as Inegy overseas) may help patients reduce cardiovascular risks better than Crestor.... Read more »
A new study at Rush University Medical Center has found that Vytorin is better at lowering LDL ("bad") cholesterol than Crestor. Vytorin, a... Read more »
A new study published in the Journal of the American Medical Association has found that Crestor is better than some other statins at increasing good... Read more »
Does taking medications like Lipitor, Crestor, or Zocor mean that people whose high cholesterol is controlled by these drugs can eat anything they... Read more »